Bangkok Competitors

Delisted . USA . 
Stock . Bangkok Dusit Medical
BDUUFDelisted Stock  USD 0.59  0.00  0.00%   
Bangkok Dusit Medical competes with M3, M3, Demant A/S, Demant AS, and Recordati Industria; as well as few others. The company classifies itself under Healthcare sector and is part of Medical Care Facilities industry. Analyzing Bangkok Dusit competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Bangkok Dusit to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Bangkok Dusit competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bangkok Dusit's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.590.590.59
Details
Intrinsic
Valuation
LowRealHigh
0.520.520.65
Details
Naive
Forecast
LowNextHigh
0.580.580.58
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.550.610.66
Details

Bangkok Dusit Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Bangkok Dusit and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Bangkok and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Bangkok Dusit Medical does not affect the price movement of the other competitor.

High positive correlations

SSMXF
+ 0.82
WILYY
SSMXF
+ 0.76
WILLF
WILLF
+ 0.73
WILYY
GIFOF
+ 0.6
RCDTF
RCDTF
+ 0.45
MTHRF
GIFOF
+ 0.37
SHPMF
  

High negative correlations

GIFOF
- 0.85
WILLF
GIFOF
- 0.84
SSMXF
RCDTF
- 0.8
WILYY
GIFOF
- 0.79
WILYY
SSMXF
- 0.78
RCDTF
RCDTF
- 0.65
WILLF

Risk-Adjusted Indicators

There is a big difference between Bangkok Pink Sheet performing well and Bangkok Dusit Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bangkok Dusit's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
MTHRF  0.50 (0.01) 0.00  0.04  0.00 
 0.00 
 0.00 
 0.00 
 21.25 
GIFLF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
MTHRY  2.59 (0.26) 0.00 (0.27) 0.00 
 0.00 
 6.77 
(4.62)
 19.64 
SFOSF  1.16  0.51  0.00  0.98  0.00 
 0.00 
 0.00 
 0.00 
 4.08 
WILYY  0.63 (0.18) 0.00 (53.01) 0.00 
 0.00 
 1.17 
(2.00)
 12.45 
WILLF  0.64 (0.16) 0.00  2.04  0.00 
 0.00 
 2.32 
(1.54)
 12.16 
RCDTF  0.03  0.00  0.00  0.12  0.00 
 0.00 
 0.00 
 0.00 
 0.97 
SSMXF  0.81 (0.44) 0.00  2.87  0.00 
 0.00 
 0.00 
(3.90)
 7.84 
SHPMF  0.95  0.46  0.00  6.85  0.00 
 0.00 
 0.00 
 0.00 
 32.57 
GIFOF  0.21  0.10  0.00 (0.79) 0.00 
 0.00 
 0.00 
 0.00 
 6.91 
All Fundamental Data

Bangkok Dusit Competitive Analysis

The better you understand Bangkok Dusit competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Bangkok Dusit's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Bangkok Dusit's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
BDUUF MTHRF GIFLF MTHRY SFOSF WILYY WILLF RCDTF SSMXF SHPMF
 0.00 
 0.59 
Bangkok
 9.77 
 13.76 
M3
 0.00 
 13.90 
Grifols
 0.45 
 6.60 
M3
 0.00 
 2.67 
Shanghai
 0.00 
 16.46 
Demant
 3.09 
 33.70 
Demant
 0.00 
 65.44 
Recordati
 0.00 
 9.33 
Sysmex
 0.00 
 1.56 
Shanghai
Market Volatility
(90 Days Market Risk)
Very steady
Not too volatile
Very steady
Slightly risky
Very steady
Not too volatile
Very steady
Very steady
Not too volatile
Very steady
Market Performance
(90 Days Performance)
Weakest
Weakest
Weakest
Weakest
Weakest
Weakest
Weakest
Fair
Weakest
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Hazard
Low
Hazard
Low
Hazard
Small
Low
Low
Low
Hazard
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Over Valued
Under Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Hold
Not Rated
Cautious Hold
Not Rated
Sell
Strong Sell
Cautious Hold
Strong Sell
Not Rated
Current Ratio
1.54
3.45
2.68
3.47
1.0
0.78
0.78
1.48
2.88
1.4
Net Asset
128.45 B
345.98 B
19.23 B
345.98 B
93.29 B
29.86 B
29.86 B
2.82 B
483.71 B
163.44 B
Profit Margin
0.13
0.2
0.0115
0.2
0.0832
0.11
0.11
0.18
0.11
0.0236
EBITDA
17.64 B
100.25 B
944.03 M
102.51 B
8.71 B
4.3 B
4.3 B
578.35 M
92.69 B
10.73 B
Operating Margin
0.17
0.31
0.0887
0.31
0.0729
0.16
0.16
0.29
0.18
0.0351
Current Valuation
13.03 B
19.27 B
16.07 B
19.27 B
15.52 B
8.18 B
7.98 B
10.45 B
13.3 B
9.42 B
Price To Book
4.35
10.14
1.04
9.69
1.45
5.38
5.49
4.89
4.74
0.67
Retained Earnings
28.38 B
46.23 B
N/A
N/A
10.37 B
6.51 B
N/A
939 M
155.56 B
14.62 B
Current Asset
12.76 B
41.38 B
N/A
N/A
10.27 B
5.06 B
N/A
594 M
172.66 B
61.39 B
Five Year Return
N/A
N/A
1.38
N/A
N/A
N/A
N/A
N/A
0.67
N/A
Beta
0.43
0.81
0.48
0.81
0.76
0.93
0.93
0.29
0.59
0.33
Number Of Employees
45
9.38 K
27.58 K
9.38 K
36.28 K
20.57 K
20.57 K
4.3 K
8.77 K
47.06 K
Shares Outstanding
15.89 B
678.95 M
422.18 M
1.36 B
551.94 M
446.37 M
223.18 M
205.46 M
209.24 M
919.07 M
Cash Flow From Operations
14.56 B
52.11 B
596.98 M
52.11 B
3.95 B
2.62 B
2.62 B
491.65 M
58.74 B
5.06 B
Annual Yield
0.0449
0.0044
0.0211
0.0044
0.0274
N/A
N/A
0.0277
0.0095
0.0348
Total Debt
12.5 B
9.02 B
6.1 B
N/A
9.05 B
6.1 B
6.1 B
1.84 B
23.85 B
7.16 B
Return On Equity
0.15
0.18
0.0182
0.18
0.0756
0.28
0.28
0.22
0.13
0.1
Z Score
N/A
1.2
0.6
N/A
0.6
0.6
0.6
2.4
N/A
1.6
Return On Asset
0.0739
0.13
0.0155
0.13
0.0204
0.071
0.071
0.0937
0.0955
0.0281
Book Value Per Share
5.41
428.26
9.32
214.13
16.3
19.18
38.36
7.83
1784.66
17.9
Current Liabilities
16.25 B
15.04 B
N/A
N/A
11.09 B
5.56 B
N/A
331 M
65.89 B
41.8 B
Total Asset
128.45 B
345.98 B
19.23 B
345.98 B
93.29 B
29.86 B
29.86 B
2.82 B
483.71 B
163.44 B
Debt To Equity
0.21
0.043
1.14
N/A
0.64
1.64
1.64
1.23
0.065
0.6
Last Dividend Paid
0.5
16.0
N/A
16.0
0.56
N/A
N/A
1.12
39.0
0.42
Shares Owned By Institutions
5.23
32.1
30.49
0.007
35.6
N/A
18.48
26.08
31.37
32.55
Market Capitalization
12.24 B
18.43 B
8.7 B
18.11 B
12.25 B
7.02 B
7.02 B
9.05 B
13.63 B
9.25 B
Price To Earning
48.99
58.38
9.52
38.08
13.8
36.83
36.39
18.62
44.34
5.36
Price To Earnings To Growth
N/A
N/A
0.53
N/A
N/A
1.72
1.75
N/A
N/A
2.32
Price To Sales
0.14
0.0912
1.34
0.0912
0.31
0.34
0.33
5.04
0.0354
0.0411
Net Income
7.94 B
63.84 B
182.8 M
63.84 B
4.74 B
2.08 B
2.08 B
385.97 M
44.09 B
5.09 B
Earnings Per Share
0.02
0.53
0.11
0.26
0.21
0.73
1.45
1.7
1.68
0.24
Shares Owned By Insiders
2.3
39.78
30.57
N/A
0.07
N/A
60.87
51.8
26.79
22.0
Revenue
74.45 B
208.16 B
4.93 B
208.16 B
39.01 B
19.7 B
19.7 B
1.58 B
363.78 B
215.82 B
Working Capital
(3.49 B)
26.34 B
N/A
N/A
(817 M)
(503 M)
N/A
263 M
106.77 B
19.59 B
Cash And Equivalents
12.66 B
141.5 B
549.09 M
129.66 B
14.64 B
1.24 B
1.24 B
373.76 M
56.23 B
37.3 B
Cash Per Share
0.8
208.43
0.81
95.49
5.49
2.73
5.46
1.82
268.76
10.09
Gross Profit
24.99 B
123.27 B
1.96 B
123.27 B
18.71 B
14.67 B
14.67 B
1.15 B
190.59 B
28.41 B
Day Typical Price
0.59
13.76
13.9
6.6
2.67
16.46
33.7
65.44
9.33
1.56
Accumulation Distribution
N/A
N/A
N/A
0.0075
N/A
N/A
N/A
N/A
N/A
N/A
Market Facilitation Index
N/A
N/A
N/A
0.05
N/A
N/A
N/A
N/A
N/A
N/A
Daily Balance Of Power
0.0
(9,223,372,036,855)
0.0
(0.60)
0.0
0.0
9.2 T
0.0
0.0
0.0
Period Momentum Indicator
N/A
(1.49)
N/A
(0.03)
N/A
N/A
1.01
N/A
N/A
N/A
Rate Of Daily Change
1.0
0.9
1.0
1.0
1.0
1.0
1.03
1.0
1.0
1.0
Day Median Price
0.59
13.76
13.9
6.61
2.67
16.46
33.7
65.44
9.33
1.56
Price Action Indicator
N/A
(0.75)
N/A
(0.02)
N/A
N/A
0.51
N/A
N/A
N/A
Coefficient Of Variation
(19,689)
10350.32
N/A
(1,959)
803.58
(989.22)
(1,026)
812.4
(374.79)
829.36
Mean Deviation
0.3211
0.5006
N/A
2.59
1.16
0.6256
0.6412
0.029
0.8136
0.9533
Jensen Alpha
(0.04)
(0.01)
N/A
(0.26)
0.5082
(0.18)
(0.16)
0.0019
(0.44)
0.4594
Total Risk Alpha
(0.20)
(0.20)
N/A
(0.58)
0.1003
(0.34)
(0.33)
(0.01)
(0.61)
0.0716
Standard Deviation
1.81
2.09
N/A
3.77
4.48
1.63
1.65
0.1197
1.65
3.93
Kurtosis
32.61
21.79
N/A
4.12
64.59
15.8
17.74
66.0
13.89
65.95
Potential Upside
N/A
N/A
N/A
6.77
N/A
1.17
2.32
N/A
N/A
N/A
Treynor Ratio
(0.06)
0.0441
N/A
(0.27)
0.9758
(53.01)
2.04
0.1159
2.87
6.85
Maximum Drawdown
20.61
21.25
N/A
19.64
4.08
12.45
12.16
0.9721
7.84
32.57
Variance
3.27
4.35
N/A
14.24
20.08
2.66
2.71
0.0143
2.72
15.47
Market Risk Adjusted Performance
(0.05)
0.0541
N/A
(0.26)
0.9858
(53.00)
2.05
0.1259
2.88
6.86
Risk Adjusted Performance
0.0025
0.0134
N/A
(0.03)
0.096
(0.07)
(0.06)
0.0378
(0.18)
0.0931
Skewness
(0.50)
0.9273
N/A
1.55
7.99
(3.07)
(3.40)
8.12
(3.84)
8.12
Information Ratio
(0.05)
(0.03)
N/A
(0.07)
0.1065
(0.15)
(0.15)
(0.55)
(0.32)
0.1002
Value At Risk
N/A
N/A
N/A
(4.62)
N/A
(2.00)
(1.54)
N/A
(3.90)
N/A

Bangkok Dusit Competition Performance Charts

Five steps to successful analysis of Bangkok Dusit Competition

Bangkok Dusit's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Bangkok Dusit Medical in relation to its competition. Bangkok Dusit's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Bangkok Dusit in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Bangkok Dusit's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Bangkok Dusit Medical, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Bangkok Dusit position

In addition to having Bangkok Dusit in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Top Crypto Assets Thematic Idea Now

Top Crypto Assets
Top Crypto Assets Theme
An experimental p2p digital currency that is accepted by many vendors in null. The Top Crypto Assets theme has 0 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Top Crypto Assets Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Consideration for investing in Bangkok Pink Sheet

If you are still planning to invest in Bangkok Dusit Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bangkok Dusit's history and understand the potential risks before investing.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY